|
AU5984494A
|
|
Prevention of suppression of immune defense against cancer caused by the cancer-associated scm-recognition peptides
|
|
AU5000893A
|
|
Immunochemical assays for cancer-associated scm recognition factor
|
|
US5270788A
|
|
Apparatus for measuring polarization of bathochromically shifted fluorescence
|
|
US5260186A
|
|
Provision of density specific blood cells for the structuredness of the cytoplasmic matrix (SCM) test
|
|
US5231002A
|
|
Synthetic SCM-active cancer recognition peptides
|
|
US5270171A
|
|
Cancer-associated SCM-recognition factor, preparation and method of use
|
|
WO9004785A1
|
|
Provision of density specific blood cells for the structuredness of the cytoplasmic matrix (scm) test
|
|
EP0407451A1
|
|
General cancer-associated scm-recognition factor, preparation and method of use
|
|
WO8908118A1
|
|
Synthetic scm-active cancer recognition peptides
|
|
US5166052A
|
|
Method for measuring polarization of bathochromically shifted fluorescence
|
|
EP0357637A1
|
|
General cancer-associated scm-recognition factor, preparation and method of use.
|
|
CA1305024C
|
|
Method for measuring polarized fluorescence emissions
|
|
AU7204987A
|
|
Separation and method of use of density specific blood cells
|
|
US4835103A
|
|
Differential binding of membrane potential sensitive materials to lymphocytes
|
